Status:
COMPLETED
Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diabetes Mellitus, Type II
Eligibility:
All Genders
18-78 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with type 2 diabetes mellitus
Exclusion
Key Trial Info
Start Date :
June 30 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2007
Estimated Enrollment :
701 Patients enrolled
Trial Details
Trial ID
NCT00086515
Start Date
June 30 2004
End Date
February 2 2007
Last Update
May 5 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.